Gastrografin 660 mg/mL (Diatrizoate Meglumine and Diatrizoate Sodium LIQUID) 660 mg/mL

Gastrografin 660 mg/mL is a diagnostic imaging solution containing diatrizoate meglumine and diatrizoate sodium. It is used to enhance visibility during X-ray procedures, aiding in the examination of the gastrointestinal tract. This liquid formulation is available in 120 mL bottles, packed in boxes of 12.

Strength

660 mg/mL

Pack Size

12 BOTTLE in 1 BOX (0270-0445-40) / 120 mL in 1 BOTTLE

Manufacturer / TM Owner

Bracco Diagnostics Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gastrografin 660 mg/mL is primarily used as a contrast agent to improve the clarity of X-ray images. It is administered orally or rectally to visualize the gastrointestinal tract, helping healthcare professionals identify abnormalities. This solution is often used in diagnostic procedures to enhance the visibility of structures within the digestive system.

Side Effects

When administered, Gastrografin 660 mg/mL may cause a temporary laxative effect, which can help clear the intestines for better imaging. Some individuals may experience mild gastrointestinal discomfort or a salty taste. These effects are generally short-lived and subside once the procedure is complete.

Precautions & Warnings

Gastrografin 660 mg/mL should be used with caution in individuals with known allergies to iodine-based contrast agents. It is important to inform healthcare providers of any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the solution.

Avoid Interactions

Gastrografin 660 mg/mL may interact with certain medications or substances, particularly those that affect kidney function. It is advisable to consult with a healthcare provider regarding potential interactions, especially if taking other medications. Alcohol and certain foods may also influence the effectiveness of the contrast agent.

Frequently Asked Questions

Gastrografin 660 mg/mL is used as a contrast agent to enhance the visibility of the gastrointestinal tract during X-ray procedures.

Gastrografin 660 mg/mL can be administered orally or rectally, depending on the specific diagnostic procedure.

Common effects include a temporary laxative effect and mild gastrointestinal discomfort, which are usually short-lived.

Precautions include informing healthcare providers of any allergies to iodine-based contrast agents and existing medical conditions.

Gastrografin 660 mg/mL may interact with medications that affect kidney function, so it is important to consult a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.